ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Other Announcement

Curis Lifesciences Other Announcement

Curis Lifesciences filed its Reg 32 statement of IPO fund utilisation for the half-year to September 30, 2026. The filing reports no deviation or variation, with ₹2,295.11 lakhs utilised against ₹2,752 lakhs proposed.

Source

NSE filing, NSE: CURIS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Curis Lifesciences Ltd: key numbers

Share price
₹170.70
Market cap
₹138.0 Cr
Revenue (annual)
₹60.63 Cr
Net profit (annual)
₹6.92 Cr
P/E (TTM)
19.9×Sector 43.8×
Promoter holding
68.03%
FII holding
1.05%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Curis Lifesciences Ltd

All →

Other other announcement announcements

All →